Cargando…
The therapeutic potential of epigenetic manipulation during infectious diseases
Epigenetic modifications are increasingly recognized as playing an important role in the pathogenesis of infectious diseases. They represent a critical mechanism regulating transcriptional profiles in the immune system that contributes to the cell-type and stimulus specificity of the transcriptional...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pergamon Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109899/ https://www.ncbi.nlm.nih.gov/pubmed/27519803 http://dx.doi.org/10.1016/j.pharmthera.2016.07.013 |
_version_ | 1782467632106045440 |
---|---|
author | Cole, Joby Morris, Paul Dickman, Mark J. Dockrell, David H. |
author_facet | Cole, Joby Morris, Paul Dickman, Mark J. Dockrell, David H. |
author_sort | Cole, Joby |
collection | PubMed |
description | Epigenetic modifications are increasingly recognized as playing an important role in the pathogenesis of infectious diseases. They represent a critical mechanism regulating transcriptional profiles in the immune system that contributes to the cell-type and stimulus specificity of the transcriptional response. Recent data highlight how epigenetic changes impact macrophage functional responses and polarization, influencing the innate immune system through macrophage tolerance and training. In this review we will explore how post-translational modifications of histone tails influence immune function to specific infectious diseases. We will describe how these may influence outcome, highlighting examples derived from responses to acute bacterial pathogens, models of sepsis, maintenance of viral latency and HIV infection. We will discuss how emerging classes of pharmacological agents, developed for use in oncology and other settings, have been applied to models of infectious diseases and their potential to modulate key aspects of the immune response to bacterial infection and HIV therapy. |
format | Online Article Text |
id | pubmed-5109899 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Pergamon Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-51098992016-11-21 The therapeutic potential of epigenetic manipulation during infectious diseases Cole, Joby Morris, Paul Dickman, Mark J. Dockrell, David H. Pharmacol Ther Associate editor: A. Doseff Epigenetic modifications are increasingly recognized as playing an important role in the pathogenesis of infectious diseases. They represent a critical mechanism regulating transcriptional profiles in the immune system that contributes to the cell-type and stimulus specificity of the transcriptional response. Recent data highlight how epigenetic changes impact macrophage functional responses and polarization, influencing the innate immune system through macrophage tolerance and training. In this review we will explore how post-translational modifications of histone tails influence immune function to specific infectious diseases. We will describe how these may influence outcome, highlighting examples derived from responses to acute bacterial pathogens, models of sepsis, maintenance of viral latency and HIV infection. We will discuss how emerging classes of pharmacological agents, developed for use in oncology and other settings, have been applied to models of infectious diseases and their potential to modulate key aspects of the immune response to bacterial infection and HIV therapy. Pergamon Press 2016-11 /pmc/articles/PMC5109899/ /pubmed/27519803 http://dx.doi.org/10.1016/j.pharmthera.2016.07.013 Text en Crown Copyright © 2016 Published by Elsevier Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Associate editor: A. Doseff Cole, Joby Morris, Paul Dickman, Mark J. Dockrell, David H. The therapeutic potential of epigenetic manipulation during infectious diseases |
title | The therapeutic potential of epigenetic manipulation during infectious diseases |
title_full | The therapeutic potential of epigenetic manipulation during infectious diseases |
title_fullStr | The therapeutic potential of epigenetic manipulation during infectious diseases |
title_full_unstemmed | The therapeutic potential of epigenetic manipulation during infectious diseases |
title_short | The therapeutic potential of epigenetic manipulation during infectious diseases |
title_sort | therapeutic potential of epigenetic manipulation during infectious diseases |
topic | Associate editor: A. Doseff |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109899/ https://www.ncbi.nlm.nih.gov/pubmed/27519803 http://dx.doi.org/10.1016/j.pharmthera.2016.07.013 |
work_keys_str_mv | AT colejoby thetherapeuticpotentialofepigeneticmanipulationduringinfectiousdiseases AT morrispaul thetherapeuticpotentialofepigeneticmanipulationduringinfectiousdiseases AT dickmanmarkj thetherapeuticpotentialofepigeneticmanipulationduringinfectiousdiseases AT dockrelldavidh thetherapeuticpotentialofepigeneticmanipulationduringinfectiousdiseases AT colejoby therapeuticpotentialofepigeneticmanipulationduringinfectiousdiseases AT morrispaul therapeuticpotentialofepigeneticmanipulationduringinfectiousdiseases AT dickmanmarkj therapeuticpotentialofepigeneticmanipulationduringinfectiousdiseases AT dockrelldavidh therapeuticpotentialofepigeneticmanipulationduringinfectiousdiseases |